Published in
Springer, Pediatric Drugs, 1(25), p. 67-77, 2022
DOI: 10.1007/s40272-022-00553-8
Links
Tools
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis
Journal article published in 2022 by
Amy S. Paller 
,
Elaine C. Siegfried,
Michael J. Cork,
Andreas Wollenberg ,
Peter D. Arkwright ,
Mercedes E. Gonzalez ,
Benjamin Lockshin,
Zhen Chen,
Ashish Bansal,
Noah A. Levit ,
Randy Prescilla
,
Elaine C. Siegfried,
Michael J. Cork,
Andreas Wollenberg ,
Peter D. Arkwright ,
Mercedes E. Gonzalez ,
Benjamin Lockshin,
Zhen Chen,
Ashish Bansal,
Noah A. Levit ,
Randy Prescilla
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 